Total planned funding: $177,422,142
Allocations
Countries/Regions
India | $177,422,142 |
Organizational Types
Unknown | $63,813,698 |
NGO | $56,610,170 |
Own Agency | $28,400,390 |
University | $15,532,112 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,860,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,539,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $71,855,970 |
Prevention | $42,764,602 |
Care | $23,844,643 |
Management and Operations | $21,045,069 |
Testing | $9,103,879 |
Treatment | $8,807,979 |
Budget Codes
OHSS: Health Systems Strengthening | $42,229,485 |
HVOP: Sexual Prevention: Other Sexual Prevention | $24,503,342 |
HVSI: Strategic Information | $23,984,632 |
HVMS: Management and Operations | $21,045,069 |
HBHC: Care: Adult Care and Support | $13,628,611 |
HVCT: Testing: HIV Testing and Counseling | $9,103,879 |
HTXS: Treatment: Adult Treatment | $8,254,484 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,518,933 |
HLAB: Laboratory Infrastructure | $5,641,853 |
HKID: Care: Orphans and Vulnerable Children | $5,553,162 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,375,472 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,057,202 |
HVTB: Care: TB/HIV | $3,839,530 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $823,340 |
PDTX: Treatment: Pediatric Treatment | $530,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$63,189,209
Countries/Regions
FHI 360:
$18,429,182
Countries/Regions
USG Aggregated Agencies:
$17,832,323
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions